1-Star Price
INVESTOR
5-Star Price
INVESTOR
Economic Moat
INVESTOR
Capital Allocation
INVESTOR
Since 2013, Abbott has continued to improve the profitability of its four segments: nutritionals, devices, diagnostics, and established pharmaceuticals. Although the company has made progress over the last 10 years, it still lags key rivals on profitability measures despite competing in businesses that are characterized by attractive margins.
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Morningstar analysts hand-select direct competitors or comparable companies to provide context on the strength and durability of ABT’s competitive advantage.
Abbott Laboratories
XNYS: ABT
| Boston Scientific Corp
XNYS: BSX
| Medtronic PLC
XNYS: MDT
| Roche Holding AG
XSWX: ROG
| |
Price
| 101.69 | 51.28 | 83.73 | 282.10 |
Currency
| USD | USD | USD | CHF |
Change
| +$0.91 (0.90%) | +$0.21 (0.41%) | +$0.63 (0.76%) | −$1.85 (0.65%) |
Market Cap
| 176.83 Bil | 73.73 Bil | 111.43 Bil | 225.45 Bil |
Industry
| Medical Devices | Medical Devices | Medical Devices | Drug Manufacturers - General |
Sector
|
Healthcare
|
Healthcare
|
Healthcare
|
Healthcare
|
* Trading data in this section is delayed by at least 15 minutes.
Yes. ABT has a forward dividend yield of 2.01%.
See
ABT’s full dividends and stock split history
on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks,
to compare the relationship between a stock’s price and how it rewards stockholders through dividends.
The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.
Learn more about dividend yield.
ABT’s market cap is 176.83 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares.
It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the
largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.
Learn more about market capitalization.
ABT’s stock style is Large Core.
Style is an investment factor that has a meaningful impact on investment risk and returns.
Style is calculated by combining value and growth scores, which are first individually calculated.
High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.
Learn more about style.
ABT’s price/sales is 4.31.
Price/sales represents the amount an investor is willing to pay for a dollar generated from
a particular company’s sales or revenues.
ABT’s price/forward earnings is 30.91.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates.
The lower the Forward P/E, the cheaper the stock.
ABT’s price/book is 4.78.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets,
based on historical, rather than current, valuations. Historical valuations generally do not reflect
a company’s current market value. Value investors frequently look for companies that have low price/book ratios.
See ABT’s valuation ratios compared to the Market Index.
ABT’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.
Compare ABT’s historical performance against its industry peers and the overall market.
